Syndax Pharmaceuticals (SNDX) Work In Process (2024 - 2026)

Syndax Pharmaceuticals' Work In Process history runs 3 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• On a quarterly basis, Work In Process rose 401.57% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 401.57% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 540.0% from the prior year.
• Work In Process improved to $2.9 million in Q1 2026 per SNDX's latest filing, from $2.1 million in the prior quarter.
• Across five years, Work In Process topped out at $2.9 million in Q1 2026 and bottomed at $330000.0 in Q4 2024.
• The 3-year median for Work In Process is $1.3 million (2025), against an average of $1.4 million.
• Across the five-year window, Work In Process surged 540.0% in 2025 and surged 401.57% in 2026, its largest moves.
• Year by year, Work In Process stood at $330000.0 in 2024, then jumped by 540.0% to $2.1 million in 2025, then soared by 35.84% to $2.9 million in 2026.
• Per Business Quant, the three latest SNDX Work In Process figures stand at $2.9 million (Q1 2026), $2.1 million (Q4 2025), and $1.4 million (Q3 2025).